Craig Travis, M.D. - Chairman of the Board, CEO (Interim) & President
Dr. Travis founded Immugen with the goal to exploit the potential of the endocannabinoid system based on the available scientific literature and available non-proprietary compounds that were known to activate the system. Initially focused on the treatment and transmission of HIV.
Bill W. Massey, Ph.D. -
Executive VP, Regulatory Affairs
Dr. Massey is a neuropharmacologist, pharmacogeneticist, life sciences professional, senior executive and entrepreneur. Dr. Massey received his Ph.D. in Pharmacology at the University of Arkansas for Medical Sciences and subsequently was an investigator at the Pritzker School of Medicine’s Drug Abuse Research Center at The University of Chicago.
David Fater, CPA -
Chief Financial Officer
David Fater, Chief Financial Officer has recruited a dynamic group of individuals with broad scientific and organizational backgrounds to take Immugen forward.
Harold "Hal" Haines, Ph.D
Dr. Haines has 45 years of executive managerial and consulting experience in the healthcare industry, with a broad background in pharmaceuticals, diagnostics, medical devices and therapeutics.